Peanut oral immunotherapy is not ready for clinical use

Ananth Thyagarajan; Pooja Varshney; Stacie M. Jones; Scott Sicherer; Robert Wood; Brian P. Vickery; Hugh Sampson; A. Wesley Burks

doi:10.1016/j.jaci.2010.05.012

Peanut oral immunotherapy is not ready for clinical use

Ananth Thyagarajan, Pooja Varshney, Stacie M. Jones, Scott Sicherer, Robert Wood, Brian P. Vickery, Hugh Sampson, A. Wesley Burks

Research output: Contribution to journal › Editorial

20 Scopus citations

Original language	English
Pages (from-to)	31-32
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology
Volume	126
Issue number	1
DOIs	https://doi.org/10.1016/j.jaci.2010.05.012
State	Published - Jul 2010
Externally published	Yes

Keywords

Peanut allergy
desensitization
oral immunotherapy

Access to Document

10.1016/j.jaci.2010.05.012

Cite this

@article{ec8ba29f29ec408bb6eaebb3aafe3412,

title = "Peanut oral immunotherapy is not ready for clinical use",

keywords = "Peanut allergy, desensitization, oral immunotherapy",

author = "Ananth Thyagarajan and Pooja Varshney and Jones, {Stacie M.} and Scott Sicherer and Robert Wood and Vickery, {Brian P.} and Hugh Sampson and Burks, {A. Wesley}",

note = "Funding Information: Disclosure of potential conflict of interest: S. M. Jones has received research support from the National Peanut Board, the National Institutes of Health (NIAID), and DYAX Corp and is on the Medical Advisory Board for the Food Allergy and Anaphylaxis Network. S. Sicherer is a consultant for the Food Allergy Initiative and has received research support from the National Institutes of Health (NIAID), the Food Allergy and Anaphylaxis Network, and the Food Allergy Initiative . R. Wood has received research support from the National Institutes of Health and is on the Medical Advisory Board for the Food Allergy and Anaphylaxis Network. B. P. Vickery has received research support from the Thrasher Research Fund and the National Institutes of Health (NIAID). H. Sampson is a consultant for Allertein, LLC; has received research support from the Food Allergy Initiative and the National Institutes of Health (NIAID); is a consultant and scientific advisor for the Food Allergy Initiative; and is 45% owner of Herbal Springs, LLC. A. W. Burks is a consultant for ActoGeniX NV, Intelliject, McNeil Nutritionals, and Novartis; is a minority stockholder in Allertein and MastCell, Inc; is on the Advisory Board for Dannon Co Probiotics; is on the expert panel for Nutricia; has received research support from the National Institutes of Health, the Food Allergy and Anaphylaxis Network, and the Wallace Research Foundation ; has served as an expert witness on the topic of food allergy; is on the Medical Board of Directors for the Food Allergy and Anaphylaxis Network; is a Dermatological Allergy Committee Member for the American College of Allergy, Asthma, and Immunology; is a Study Section Member for the National Institutes of Health (HAI); and is on the Reviewer Board for the Journal of Allergy and Clinical Immunology and the US Food and Drug Administration. The rest of the authors have declared that they have no conflict of interest. ",

year = "2010",

month = jul,

doi = "10.1016/j.jaci.2010.05.012",

language = "English",

volume = "126",

pages = "31--32",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "1",

}

TY - JOUR

T1 - Peanut oral immunotherapy is not ready for clinical use

AU - Thyagarajan, Ananth

AU - Varshney, Pooja

AU - Jones, Stacie M.

AU - Sicherer, Scott

AU - Wood, Robert

AU - Vickery, Brian P.

AU - Sampson, Hugh

AU - Burks, A. Wesley

N1 - Funding Information: Disclosure of potential conflict of interest: S. M. Jones has received research support from the National Peanut Board, the National Institutes of Health (NIAID), and DYAX Corp and is on the Medical Advisory Board for the Food Allergy and Anaphylaxis Network. S. Sicherer is a consultant for the Food Allergy Initiative and has received research support from the National Institutes of Health (NIAID), the Food Allergy and Anaphylaxis Network, and the Food Allergy Initiative . R. Wood has received research support from the National Institutes of Health and is on the Medical Advisory Board for the Food Allergy and Anaphylaxis Network. B. P. Vickery has received research support from the Thrasher Research Fund and the National Institutes of Health (NIAID). H. Sampson is a consultant for Allertein, LLC; has received research support from the Food Allergy Initiative and the National Institutes of Health (NIAID); is a consultant and scientific advisor for the Food Allergy Initiative; and is 45% owner of Herbal Springs, LLC. A. W. Burks is a consultant for ActoGeniX NV, Intelliject, McNeil Nutritionals, and Novartis; is a minority stockholder in Allertein and MastCell, Inc; is on the Advisory Board for Dannon Co Probiotics; is on the expert panel for Nutricia; has received research support from the National Institutes of Health, the Food Allergy and Anaphylaxis Network, and the Wallace Research Foundation ; has served as an expert witness on the topic of food allergy; is on the Medical Board of Directors for the Food Allergy and Anaphylaxis Network; is a Dermatological Allergy Committee Member for the American College of Allergy, Asthma, and Immunology; is a Study Section Member for the National Institutes of Health (HAI); and is on the Reviewer Board for the Journal of Allergy and Clinical Immunology and the US Food and Drug Administration. The rest of the authors have declared that they have no conflict of interest.

PY - 2010/7

Y1 - 2010/7

KW - Peanut allergy

KW - desensitization

KW - oral immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=77954120475&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2010.05.012

DO - 10.1016/j.jaci.2010.05.012

M3 - Editorial

C2 - 20620564

AN - SCOPUS:77954120475

SN - 0091-6749

VL - 126

SP - 31

EP - 32

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 1

ER -